: Boston Scientific to acquire Relievant Medsystems for $850 million upfront, plus milestone payment

Boston Scientific Corp. BSX said Tuesday it has entered an agreement to acquire Relievant Medsystems Inc., a privately held medical tech company that has developed a treatment for a form of chronic low back pain. Boston Scientific will pay $850 million upfront and additional but undisclosed contingent payments based on reaching certain sales goals over the next three years. Relievant has developed the Intracept (R) Intraosseous Nerve Ablation System to treat vertebrogenic pain, the only...